Navigation Links
£3m drug safety center investment
Date:1/29/2014

LIVERPOOL, UK 29 January 2014: The Medical Research Council (MRC) Centre for Drug Safety Science at the University of Liverpool has received three million pounds of new funding from MRC to allow it to continue reducing the impact of adverse reactions to medicinal drugs.

Adverse drug reactions result in one in 15 hospital admissions and cost the NHS in excess of 650 million every year. They are also a significant cause of drug attrition for the pharmaceutical industry. The Centre addresses these problems by gaining an understanding of the fundamental mechanisms that drive adverse drug reactions to improve patient care.

The new funding will allow the Centre to consolidate its main areas of research on drug-induced liver injury and drug-induced skin hypersensitivity, for which it is internationally renowned. The funding will also enable the development of new expertise in the significant clinical problem of gastrointestinal drug toxicity.

Training is a significant part of the Centre's mission and the funding will allow it to continue to train the next generation of clinical and non-clinical drug safety scientists to bridge the skills gap in this area for pharmaceutical companies, the biotechnology sector, contract research organisations and academia.

The Centre works alongside partners from academia, regulatory authorities and industry and has attracted over 16 million in additional funding since it was set up in 2008.

Professor Kevin Park, Director of the Centre said: "This is good news for the University of Liverpool and highlights the value that the MRC sees in our national centre of excellence. It is also good news for the people who are affected by adverse reactions to medicines".

Professor Munir Pirmohamed, Head of Department of Pharmacology said: "This highlights the critical mass of expertise we have in drug safety in Liverpool. The new funding and new equipment will allow us to continue to train scientists and clinicians and translate our research into both medical practice and drug development processes. Ultimately we want to make drugs much safer for everybody."

Dr Nathan Richardson, Head of Molecular and Cellular Medicine, MRC said: "The Centre has built up an impressive bio-analytical and training facility in the first five years of core funding, with partnerships between academics, clinicians, industry and regulatory authorities.

"Positioned as a key part of MRC's portfolio in drug safety science research, we are delighted to continue strategic support for the Centre, and look forward to seeing increasing impact of its research in clinical care, including through the new research area of gastrointestinal toxicity."


'/>"/>

Contact: Jamie Brown
jamie.brown@liverpool.ac.uk
44-151-794-2248
University of Liverpool
Source:Eurekalert

Related biology news :

1. Scientists awarded £3M to study the way Northwest European seas absorb carbon
2. Aspartame passes stiff review by European Food Safety Authority
3. Safety in numbers? Not so for corals
4. Duke wins $15 million renewal to study nanotech safety
5. UH among Texas institutions that will lead Ocean Energy Safety Institute
6. Findings announced from landmark study on safety of adolescent bariatric surgery
7. Reassuring findings released in national study of influenza vaccine safety in pregnancy
8. Seafood still considered a good source of nutrients but consumers confused on safety
9. RNA-interference pesticides will need special safety testing
10. Revolutionary Face Recognition Media Exploitation System Now Available to Enhance Public Safety in Europe
11. Additional research must be done to ensure safety of pit latrines, new study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ARMONK, N.Y. , Aug. 23, 2017  The general public,s help ... the human microbiome—the bacteria that live in and on the human body ... ... bacteria in the human microbiome, starting with the gut. The project's goal ... in disease. Photo credit: IBM ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... , ... October 09, 2017 , ... At its national ... Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has been ... a member of the winning team for the 2015 Breakthrough Prize in Fundamental physics ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... and applications consulting for microscopy and surface analysis, Nanoscience Instruments is now ... Analytical offers a broad range of contract analysis services for advanced applications. ...
(Date:10/6/2017)... (PRWEB) , ... October 06, 2017 , ... ... entrepreneurship within the healthcare and technology sector at their fourth annual Conference where ... featuring 30 inspiring speakers and the ELEVATE pitch competition showcasing early stage digital ...
(Date:10/5/2017)... , ... October 05, 2017 , ... Understanding the microbiome, ... frontiers in human health. Gut Love: You Are My Future, the newest exhibit on ... perspective as it explores the human condition through the lens of the gut microbiome. ...
Breaking Biology Technology: